Two new appointments at Eastbound Shanghai Institute
This article was originally published in Scrip
Executive Summary
Eastbound Shanghai Institute, a subsidiary of Eastbound Synopharma (China), has appointed Dr Young Lo as research fellow, effective November 16th, and Chris Vance as vice-president for sales, marketing and business development. Dr Lo has more than 35 years' experience in chemical process development in the pharmaceutical industry, having previously worked at A H Robins, DuPont Merck and Boehringer Ingelheim. Mr Vance has more than 30 years of experience in the chemical and pharmaceutical industry, having formerly served as head of the sales and marketing team at Boehringer Ingelheim Chemicals.